TC-S 7006 is a selective Tpl2 (Cot; MAP3K8) inhibitor. References: Chorzalska A, Ahsan N, Rao RSP, Roder K, Yu X, Morgan J, Tepper A, Hines S, Zhang P, Treaba DO, Zhao TC, Olszewski AJ, Reagan J, Liang O, Gruppuso PA, Dubielecka PM. Overexpression of Tpl2 is linked to imatinib resistance and activation of MEK-ERK and NF-κB pathways in a model of Chronic Myeloid Leukemia. Mol Oncol. 2018 Feb 27. doi: 10.1002/1878-0261.12186. [Epub ahead of print] PubMed PMID: 29485707.

纯度：≥98%

CAS：871307-18-5